Research and Innovation
In this Q&A series, Jason Faris, MD details some exciting and innovating early-phase trials underway at the cancer center.
Programming machine learning for cervical cancer screening, aiding survival of cancer-fighting immune cells, and measuring clinician emotion during difficult conversations. These are just some of the new cancer research studies funded by The Prouty.
What are the flashes of light patients report seeing during brain radiotherapy, even with their eyes closed? Norris Cotton Cancer Center scientists record this phenomenon for the first time and provide an explanation.
In this Q&A series, Jason Faris, MD, director of the Early-Phase Trials Program at Norris Cotton Cancer Center explains what early-phase clinical trials are and why they are so important to the advancement of cancer care.
Research in therapies for drug-resistant cancers, technologies to study “guardian” proteins, adapting robotic surgery tools and the world’s fastest single-photon camera are underway, funded by The Prouty.
A new program will create dedicated time to assist Dartmouth-Hitchcock Health clinicians in researching causes of and cures for cancer.
Dartmouth researchers are leading the way on cutting-edge computer technologies that could provide clinicians with great new tools for cancer screening, diagnosis, prognosis and more.
Studies on post-weight-loss surgery diets, access to health insurance and a particular vitamin’s valuable action in cancer treatment are underway thanks to research funds raised at the 36th Prouty.
A new machine learning method can predict the likelihood that a high-risk type of breast lesion is cancerous, potentially saving some women from unnecessary breast surgeries and overtreatment.
Norris Cotton Cancer Center researchers begin five new pilot research projects funded by money raised at the 37th annual Prouty.